Published Online: Wednesday, August 1, 2007

Organized medicine has called on federal and state regulators to investigate whether in-store pharmacy-chain health clinics are creating conflicts of interest for drug chain pharmacists.

The American Medical Association (AMA) adopted a resolution vowing to seek an investigation after several AMA doctors complained that the clinics "interfere with the traditional practice of medicine." Specifically, AMA wants investigators to determine whether drug chain?owned clinics engage in conflict of interest situations when they recommend that patients have their prescriptions filled on site. AMA also wants to prohibit arrangements under which Rx insurers lower or eliminate prescription copays for patients of the in-store clinics.

Visit ePharmacy Times at for a related article.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues